Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | LAP3 | P28838 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RBP4 | P02753 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30526475 | 1.00 | ALDH1A1 (0.44) | ALDH1A1SRCGPR84NPSR1POLB | |
| SCHEMBL17491582 | 0.91 | GPR84 (0.36) | ALDH1A1SRCGPR84NPSR1TDP1 | |
| SCHEMBL15352129 | 0.91 | CA2 (0.39) | ALDH1A1SRCGPR84NPSR1TDP1 | |
| SCHEMBL28547609 | 0.89 | ALDH1A1 (0.44) | ALDH1A1SRCGPR84NPSR1POLB | |
| SCHEMBL31684848 | 0.88 | ALDH1A1 (0.48) | ALDH1A1SRCGPR84NPSR1POLB | |
| SCHEMBL6891159 | 0.88 | ALDH1A1 (0.48) | ALDH1A1SRCGPR84NPSR1POLB | |
| SCHEMBL510991 | 0.85 | NPSR1 (0.37) | ALDH1A1SRCNPSR1TDP1ATM | |
| SCHEMBL3421541 | 0.85 | NPSR1 (0.37) | ALDH1A1SRCNPSR1TDP1ATM | |
| SCHEMBL11556403 | 0.82 | SRC (0.53) | ALDH1A1SRCGPR84NPSR1POLB | |
| SCHEMBL2138387 | 0.82 | ALDH1A1 (0.41) | ALDH1A1SRCGPR84POLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3571244-B1 | FOAMED COMPOSITION | DSM IP ASSETS BV (NL) | 2022-03-16 | — | — | EP | claimed |
| WO-2018134166-A1 | FOAMED COMPOSITION | DSM INTELLECTUAL PROPERTY (NL) | 2018-07-26 | — | — | WO | claimed |
| EP-2446005-B1 | ANTI-WEAR AGENTS WITH A REDUCED NEUROTOXICITY | NYCO (FR) | 2015-04-29 | — | — | EP | claimed |
| EP-2446005-A1 | ANTI-WEAR AGENTS WITH A REDUCED NEUROTOXICITY | Nyco SA (FR) | 2012-05-02 | — | — | EP | claimed |
| US-20120101015-A1 | ANTI-WEAR AGENTS WITH A REDUCED NEUROTOXICITY | NYCO SA (FR) | 2012-04-26 | — | — | US | claimed |
| JP-4683726-B2 | — | — | 2011-05-18 | — | — | JP | claimed |
| WO-2010149690-A1 | ANTI-WEAR AGENTS WITH A REDUCED NEUROTOXICITY | NYCO SA (FR) | 2010-12-29 | — | — | WO | claimed |
| EP-1115728-B1 | TRIARYL PHOSPHATE ESTER COMPOSITION | AKZO NOBEL NV (NL) | 2003-03-12 | — | — | EP | claimed |
| JP-2002526571-A | — | — | 2002-08-20 | — | — | JP | claimed |
| EP-1115728-A1 | TRIARYL PHOSPHATE ESTER COMPOSITION | Akzo Nobel N.V. (NL) | 2001-07-18 | — | — | EP | claimed |
| US-6242631-B1 | Triaryl phosphate ester composition | AKZO NOBEL NV (NL) | 2001-06-05 | — | — | US | claimed |
| WO-2000017210-A1 | TRIARYL PHOSPHATE ESTER COMPOSITION | AKZO NOBEL N.V. (NL) | 2000-03-30 | — | — | WO | claimed |
| US-12404402-B2 | Foamed composition | ENVALIOR B.V. (NL) | 2025-09-02 | — | — | US | disclosed |
| CN-115279870-B | Lubricating oil composition | 出光兴产株式会社 | 2024-12-10 | — | — | CN | disclosed |
| CN-118974223-A | Lubricating oil composition | 出光兴产株式会社 | 2024-11-15 | — | — | CN | disclosed |
| CN-118043437-A | Lubricating oil composition, lubricating method and transmission | 出光兴产株式会社 | 2024-05-14 | — | — | CN | disclosed |
| EP-0077102-B1 | RECLAMATION OF ORGANOPHOSPHATE FLUIDS | STAUFFER CHEMICAL COMPANY (US) | 1986-07-09 | — | — | EP | disclosed |
| US-4469644-A | CATALYTIC OXIDATION OF CORRESPONDING PHOISPHITE | BORG-WARNER CHEMICALS, INC. (US) | 1984-09-04 | — | — | US | disclosed |
| US-4402883-A | BASIFICATION WITH ACTIVE ALUMINA, REGENERATION | STAUFFER CHEMICAL CO. (US) | 1983-09-06 | — | — | US | disclosed |
| EP-0077102-A2 | Reclamation of organophosphate fluids | STAUFFER CHEMICAL COMPANY (US) | 1983-04-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101015-A1 | ANTI-WEAR AGENTS WITH A REDUCED NEUROTOXICITY | SSB, PRNP, TARDBP | ALDH1A1 1160/4885SRC 1974/4885GPR84 3461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.